World Health Organization Issues Warning Over Critical Lack of Weight-Loss Injections
Less than one in 10 patients eligible to benefit from weight-loss injections like Wegovy are able to get them, states the WHO as it releases its first recommendations on the therapies.
With over a billion individuals worldwide currently classified as obese, it is advocating for broader and more equitable availability to GLP-1 medication.
Per projections, in excess of 2,000,000,000 are projected to be obese by 2030 if no action is taken.
"Our new guidance recognises that obesity is a chronic disease that can be managed with holistic and ongoing care," stated WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and logistical bottlenecks are major obstacles to universal availability to the jabs that can help people shift significant weight, notes the agency.
GLP-1 Therapy Scarcity
Despite the present most optimistic scenario, the supply of such drugs could only cover around 100 million people – under 10% of eligible patients, according to the health organization.
The guideline calls on nations and manufacturers to increase availability, by strategies like patent sharing.
Exclusive production rights on the active ingredient – the core ingredient of a leading brand – is scheduled to end in a number of nations in 2026.
The Way Obesity Jabs Operate
These medications replicate a body's own hormone to reduce digestion speed, suppress the appetite and increase the sense of being full so individuals reduce food intake.
Individuals typically start to lose weight within a few weeks of starting on the regular doses.
Research points to users may see weight return a year later of halting the medication, because their usual hunger resume.
Being carrying excess weight elevates your likelihood for contracting medical conditions, such as type 2 diabetes, heart disease, brain attack, and some malignancies.
Excess weight concerns people in countries worldwide and was responsible for millions of fatalities worldwide in 2024, according to the WHO.
